Elevated levels of type II IFN (IFN-γ) have also been observed in anti-MDA5+ DM patients with RP-ILD, suggesting a role for dysregulated IFN signaling in disease pathogenesis (14, 15). The gene discussed is IFNA1; the disease is dermatomyositis.